Found 2 hits Enz. Inhib. hit(s) with Target = 'Glucagon receptor' and Ligand = 'BDBM50007237' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007237
(CHEMBL3238224)Show SMILES COc1cccc(c1)C1=N[C@@]2(CC[C@@H](CC2)C(C)(C)C)N([C@H](CCC(C)(C)C)c2ccc(cc2)C(=O)NCc2nn[nH]n2)C1=O |r,wU:13.17,21.23,wD:10.11,t:9,(60.9,-33.41,;60.14,-32.07,;58.6,-32.06,;57.83,-30.72,;56.29,-30.71,;55.52,-32.04,;56.28,-33.38,;57.82,-33.39,;55.5,-34.71,;53.96,-34.77,;53.54,-36.25,;52.36,-35.26,;50.91,-35.79,;50.65,-37.31,;51.83,-38.3,;53.28,-37.76,;49.21,-37.84,;48.02,-36.86,;47.76,-38.38,;48.95,-39.36,;54.82,-37.11,;54.88,-38.64,;53.55,-39.43,;53.57,-40.97,;52.25,-41.75,;52.27,-43.29,;50.9,-41,;50.91,-42.51,;56.2,-39.43,;56.18,-40.97,;57.51,-41.76,;58.85,-41.01,;58.87,-39.47,;57.55,-38.68,;60.18,-41.8,;60.15,-43.34,;61.51,-41.04,;62.84,-41.83,;64.18,-41.07,;65.58,-41.71,;66.62,-40.58,;65.87,-39.24,;64.36,-39.54,;56.03,-36.16,;57.51,-36.57,)| Show InChI InChI=1S/C35H47N7O3/c1-33(2,3)18-17-28(23-11-13-24(14-12-23)31(43)36-22-29-38-40-41-39-29)42-32(44)30(25-9-8-10-27(21-25)45-7)37-35(42)19-15-26(16-20-35)34(4,5)6/h8-14,21,26,28H,15-20,22H2,1-7H3,(H,36,43)(H,38,39,40,41)/t26-,28-,35-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from recombinant human GCGR expressed in CHO cells after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007237
(CHEMBL3238224)Show SMILES COc1cccc(c1)C1=N[C@@]2(CC[C@@H](CC2)C(C)(C)C)N([C@H](CCC(C)(C)C)c2ccc(cc2)C(=O)NCc2nn[nH]n2)C1=O |r,wU:13.17,21.23,wD:10.11,t:9,(60.9,-33.41,;60.14,-32.07,;58.6,-32.06,;57.83,-30.72,;56.29,-30.71,;55.52,-32.04,;56.28,-33.38,;57.82,-33.39,;55.5,-34.71,;53.96,-34.77,;53.54,-36.25,;52.36,-35.26,;50.91,-35.79,;50.65,-37.31,;51.83,-38.3,;53.28,-37.76,;49.21,-37.84,;48.02,-36.86,;47.76,-38.38,;48.95,-39.36,;54.82,-37.11,;54.88,-38.64,;53.55,-39.43,;53.57,-40.97,;52.25,-41.75,;52.27,-43.29,;50.9,-41,;50.91,-42.51,;56.2,-39.43,;56.18,-40.97,;57.51,-41.76,;58.85,-41.01,;58.87,-39.47,;57.55,-38.68,;60.18,-41.8,;60.15,-43.34,;61.51,-41.04,;62.84,-41.83,;64.18,-41.07,;65.58,-41.71,;66.62,-40.58,;65.87,-39.24,;64.36,-39.54,;56.03,-36.16,;57.51,-36.57,)| Show InChI InChI=1S/C35H47N7O3/c1-33(2,3)18-17-28(23-11-13-24(14-12-23)31(43)36-22-29-38-40-41-39-29)42-32(44)30(25-9-8-10-27(21-25)45-7)37-35(42)19-15-26(16-20-35)34(4,5)6/h8-14,21,26,28H,15-20,22H2,1-7H3,(H,36,43)(H,38,39,40,41)/t26-,28-,35-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-stimulated cAMP production preincubated for 30 mins follo... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Search and Browse
